Skadden, Arps, Slate, Meagher & Flom LLP and Roschier advised Nokia on the transaction, and Wilson Sonsini Goodrich & Rosati advised Infinera. Nokia (NYSE: NOK) and...
Nokia’s Acquisition of Infinera
Edgewise Therapeutics’ $240 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Edgewise Therapeutics on the transaction, and Cooley represented the underwriters. Edgewise Therapeutics, Inc. (“Edgewise”) (NASDAQ: EWTX) announced the pricing of an underwritten...
Yalo’s $20 Million Series C Round Extension
Wilson Sonsini Goodrich & Rosati represented Yalo in the transaction. Yalo announced it has secured $20 million Series C extension, through partnership with Glisco Partners that will offer commercial...
Alaska Airlines’ US$1.9 Billion Acquisition of Hawaiian Airlines
O’Melveny advised Alaska Airlines on the deal, and Wilson Sonsini Goodrich & Rosati advised Hawaiian Airlines. Alaska Airlines, which serves more than 120 destinations across the...
Cyclo Therapeutics’ Acquisition of Applied Molecular Transport
Fox Rothschild LLP is acting as legal advisor to Cyclo Therapeutics and Wilson Sonsini Goodrich & Rosati, P.C. is acting as legal advisor to Applied Molecular...
IGM Biosciences’ Upsized Follow-On Offering
Wilson Sonsini Goodrich & Rosati advised IGM Biosciences, Inc. on the transaction. IGM Biosciences, Inc. (IGM) announced the closing of its previously announced upsized underwritten public offering...
Cajal Neuroscience’s $96 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Cajal Neuroscience on the deal. Cajal Neuroscience Inc., a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to...
Hawaiian Airlines’ Cargo Deal with Amazon
Wilson Sonsini and Winstead PC advised Hawaiian Airlines on the deal. Hawaiian Holdings, Inc., the parent company of Hawaiian Airlines, Inc., announced an agreement with Amazon.com,...
Turntide Technologies’ $80 Million Fundraise
Wilson Sonsini Goodrich & Rosati advised Turntide Technologies on the deal. Turntide Technologies announced that it has secured $80 million in equity funding, valuing the company...
IGM Biosciences’ $230 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised IGM on the transaction. IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its...
Turntide’s $225 Million Financing
Wilson Sonsini Goodrich & Rosati advised Turntide Technologies on the deal. Turntide Technologies, the company responsible for the Smart Motor SystemTM, announced the completion of $225...
Applied Molecular Transport’s $105 Million Public Offering
Wilson Sonsini Goodrich & Rosati advised Applied Molecular Transport on the deal. Applied Molecular Transport (AMT), a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to...